Ideally, antiplatelet therapy could be individualized, incorporating a validated assessment of ischemic and bleeding risks and perhaps CYP2C19 genotyping. A point-of-care test determining ...

Bentracimab is an investigational human monoclonal antibody fragment that binds to ticagrelor, an oral P2Y 12 platelet inhibitor, reversing its antiplatelet effects. The BLA submission is supported by ...

The mode of action of aspirin as an antiplatelet agent is through an irreversible ... the Society for Cardiovascular Angiography and Interventions Drug-eluting Task Force published an excellent ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...

GREEN BAY (WLUK) – One of the suspects in a drug-deal related murder was found competent to stand trial Friday, and the criminal case against him will resume. Elijah White, 18, is charged with ...

All of the studies used aspirin as the antiplatelet therapy. The researchers found that apixaban had similar rates of major bleeding and intracranial hemorrhage compared with aspirin (risk ...

But their relationship had started to fray when — with success in sight — Kaspar became part owner of AveXis, a biotech startup that had snapped up the rights to his SMA drug. Billions of ...

1. In this systematic review and meta-analysis, de-escalating dual antiplatelet therapy to ticagrelor monotherapy following implantation of a drug-eluting stent was associated with a lower major ...

With the length of ICU stay, and in-hospital mortality as the outcomes, antiplatelet and anticoagulant drugs use was evaluated from ICU admission ... morphine user and 2007 fentanyl user. The flow ...

Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent ...

1 Interventional Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) (Quebec Heart and Lung Institute), Quebec City, Quebec, Canada Background Many patients delay or ...